UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy

Biomedicines, 2022-08, Vol.10 (9), p.2099

Pachner, Andrew

2022

Volltextzugriff (PDF)

The Neuroimmunology of Multiple Sclerosis: Fictions and Facts

Frontiers in neurology, 2022-02, Vol.12, p.796378

Pachner, Andrew R

2022

Volltextzugriff (PDF)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

Drugs (New York, N.Y.), 2014-04, Vol.74 (6), p.659-674

2014

Volltextzugriff (PDF)

High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis

PloS one, 2016-07, Vol.11 (7), p.e0160071-e0160071

2016

Volltextzugriff (PDF)

The neurotropic herpes viruses: herpes simplex and varicella-zoster

Lancet neurology, 2007-11, Vol.6 (11), p.1015-1028

2007

Volltextzugriff (PDF)

The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome

International journal of molecular sciences, 2023-07, Vol.24 (13), p.11050

2023

Volltextzugriff (PDF)

Experimental models of multiple sclerosis

Current opinion in neurology, 2011-06, Vol.24 (3), p.291-299

Pachner, Andrew R

2011

Volltextzugriff (PDF)

Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis

Frontiers in immunology, 2021-06, Vol.12, p.676686-676686

2021

Volltextzugriff (PDF)

Lyme neuroborreliosis: infection, immunity, and inflammation

Lancet neurology, 2007-06, Vol.6 (6), p.544-552

2007

Volltextzugriff (PDF)

SeXX Matters in Multiple Sclerosis

Frontiers in neurology, 2020-07, Vol.11, p.616

2020

Volltextzugriff (PDF)

Lack of Convincing Evidence That Borrelia burgdorferi Infection Causes Either Alzheimer Disease or Lewy Body Dementia

Clinical infectious diseases, 2022-08, Vol.75 (2), p.342-346

2022

Volltextzugriff (PDF)

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis

Frontiers in immunology, 2019-08, Vol.10, p.1821-1821

2019

Volltextzugriff (PDF)

Divergent complement system activation in two clinically distinct murine models of multiple sclerosis

Frontiers in immunology, 2022-07, Vol.13, p.924734-924734

2022

Volltextzugriff (PDF)

Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis

Journal of neuroinflammation, 2019-05, Vol.16 (1), p.109-109, Article 109

2019

Volltextzugriff (PDF)

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2020-10, Vol.6 (4), p.2055217320981396-2055217320981396

2020

Volltextzugriff (PDF)

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Lancet neurology, 2010-07, Vol.9 (7), p.740-750

2010

Volltextzugriff (PDF)

Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler’s virus model mirror those in multiple sclerosis

Cytokine (Philadelphia, Pa.), 2015-12, Vol.76 (2), p.577-580

2015

Volltextzugriff (PDF)

The immune response in the CNS in Theiler’s virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response

Journal of neurovirology, 2016-02, Vol.22 (1), p.66-79

2016

Volltextzugriff (PDF)

Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on "Chemokine CXCL13 in serum, CSF, and blood-CSF barrier function"

Fluids and barriers of the CNS, 2021-02, Vol.18 (1), p.9-9, Article 9

2021

Volltextzugriff (PDF)

Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis

Journal of neuroimmunology, 2011-03, Vol.232 (1), p.35-40

2011

Volltextzugriff (PDF)

Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis

Journal of neuroimmunology, 2017-12, Vol.313, p.34-40

2017

Volltextzugriff (PDF)

Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide

Journal of neurovirology, 2017-12, Vol.23 (6), p.825-838

2017

Volltextzugriff (PDF)

Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease

mBio, 2017-07, Vol.8 (4)

2017

Volltextzugriff (PDF)

The multiple sclerosis severity score (MSSS) predicts disease severity over time

Journal of the neurological sciences, 2009-03, Vol.278 (1), p.66-70

2009

Volltextzugriff (PDF)

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Journal of visualized experiments, 2016-11 (117)

2016

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(161)

Sprache

Englisch
(161)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy

The Neuroimmunology of Multiple Sclerosis: Fictions and Facts

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis

The neurotropic herpes viruses: herpes simplex and varicella-zoster

The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome

Experimental models of multiple sclerosis

Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis

Lyme neuroborreliosis: infection, immunity, and inflammation

SeXX Matters in Multiple Sclerosis

Lack of Convincing Evidence That Borrelia burgdorferi Infection Causes Either Alzheimer Disease or Lewy Body Dementia

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis

Divergent complement system activation in two clinically distinct murine models of multiple sclerosis

Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler’s virus model mirror those in multiple sclerosis

The immune response in the CNS in Theiler’s virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response

Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on "Chemokine CXCL13 in serum, CSF, and blood-CSF barrier function"

Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis

Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis

Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide

Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease

The multiple sclerosis severity score (MSSS) predicts disease severity over time

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Suchergebnisse filtern